|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/30 | |
| C07K 14/705 | |||
| C07K 16/28 | |||
| A61K 39/395 | |||
| A61P 35/00 | |||
| A61K 38/17 | |||
| A61K 38/04 |
| (11) | Number of the document | 2250201 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09706983.5 |
| Date of filing the European patent application | 2009-01-29 | |
| (97) | Date of publication of the European application | 2010-11-17 |
| (45) | Date of publication and mention of the grant of the patent | 2014-04-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/000576 |
| Date | 2009-01-29 |
| (87) | Number | WO 2009/097128 |
| Date | 2009-08-06 |
| (30) | Number | Date | Country code |
| 62901 P | 2008-01-29 | US |
| (72) |
RITTER, Gerd, US
YIN, Beatrice, US
MURRAY, Anne, US
MARK, George, US
OLD, Lloyd, US
LLOYD, Kenneth, US
SOUCHELNYTSKIY, Serhiy, SE
GOUT, Ivan, GB
FILONENKO, Viktorovich, UA
KIYAMOVA, Ramziya, UA
|
| (73) |
Ludwig Institute for Cancer Research Ltd.,
666 Third Avenue 28th Floor, New York, NY 10017,
US
Institute Of Molecular Biology And Genetics National Academy of Sciences of Ukraine, 150 Zabolotnogo str., 03143 Kyiv, UA Sloan-kettering Institute For Cancer Research, 1275 York Avenue, New York, NY 10065, US |
| (54) | MEMBRANE TRANSPORTER NAPI2B (SLC34A2) EPITOPE FOR ANTIBODY THERAPY, ANTIBODIES DIRECTED THERETO, AND TARGET FOR CANCER THERAPY |
| MEMBRANE TRANSPORTER NAPI2B (SLC34A2) EPITOPE FOR ANTIBODY THERAPY, ANTIBODIES DIRECTED THERETO, AND TARGET FOR CANCER THERAPY |